Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Leading to a fullness and satisfaction with smaller meal sizes
Increased intra- and extracellular concentrations of -glutamylglutamate and related dipeptides in the ischemic rat striatum: Involvement of -glutamyltranspeptidase
Image credit: KaterynaBorodina/Shutterstock.com In a recent study published in the International Journal of Obesity , a group of researchers examined whether people experience stigma after losing or regaining weight following the use and discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1RAs) medications
This personalized approach offers a ray of hope in the often daunting journey of weight loss
Stay updated on stories like this Get news delivered to your inbox One in eight American adults currently takes a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition a figure that has risen significantly since 2023, according to a November 2025 Kaiser Family Foundation Health Tracking Poll
Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and quality of life in rectal cancer: post hoc analysis of a randomized controlled trial
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
